CN Patent

CN107669664B — 经呼吸递送活性剂的组合物及相关方法和系统

Assigned to Pearl Therapeutics Inc · Expires 2020-07-10 · 6y expired

What this patent protects

本发明提供了通过定量吸入器经肺或经鼻递送活性剂的组合物、方法及系统。在一个实施方式中，该组合物包含悬浮介质、活性剂颗粒及悬浮颗粒，其中活性剂颗粒和悬浮颗粒在悬浮介质中形成共悬浮液。

USPTO Abstract

本发明提供了通过定量吸入器经肺或经鼻递送活性剂的组合物、方法及系统。在一个实施方式中，该组合物包含悬浮介质、活性剂颗粒及悬浮颗粒，其中活性剂颗粒和悬浮颗粒在悬浮介质中形成共悬浮液。

Drugs covered by this patent

Patent Metadata

Patent number: CN107669664B
Jurisdiction: CN
Classification: —
Expires: 2020-07-10
Drug substance claim: No
Drug product claim: No
Assignee: Pearl Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.